天元生物有限公司 - 收益表 (TTM)

天元生物有限公司
KR ˙ KOSDAQ
₩6,210.00 0.00 (0.00%)
2026-06-05
分享價格
收益表 (TTM)

天元生物有限公司收益表顯示了一段時間內收入和支出的變化。收益表的數據包括銷售和收入、毛利、研發開支(R&D)、銷售、一般及行政開支(SG&A)、營業利潤、所得稅開支、財務成本、非營業收益、每股盈利(EPS)和已發行股份。

除以每股為單位的數字外,所有數字為1,000,000倍數。

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
收入 1,053 1,236 57 83 207 6,079 9,118 9,292 10,131 5,446 4,899 6,690 7,910 7,671 6,792 6,907 7,334 9,323 12,289 13,133
改變 (%) 17.44 -95.41 45.97 149.93 2,833.79 49.98 1.91 9.03 -46.24 -10.05 36.57 18.22 -3.02 -11.45 1.69 6.18 27.12 31.81 6.87
佔收入的百分比 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
銷售成本 1,220 2,432 3,691 4,844 5,083 5,497 6,262 7,244 8,155
改變 (%) 99.30 51.78 31.24 4.93 8.14 13.91 15.69 12.56
佔收入的百分比 18.24 30.74 48.12 71.32 73.60 74.95 67.16 58.95 62.09
營業毛利 1,053 1,236 57 83 207 6,079 9,118 9,292 10,131 5,446 4,899 5,470 5,478 3,980 1,948 1,824 1,837 3,061 5,044 4,978
改變 (%) 17.44 -95.41 45.97 149.93 2,833.79 49.98 1.91 9.03 -46.24 -10.05 11.66 0.14 -27.35 -51.05 -6.38 0.73 66.66 64.78 -1.31
佔收入的百分比 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 81.76 69.26 51.88 28.68 26.40 25.05 32.84 41.05 37.91
銷售、一般及行政費用 4,138 4,386 5,008 5,929 6,421 8,671 9,999 11,080 11,799 11,259 11,610 10,706 10,309 9,259 7,368 7,557 7,405 7,523 7,981 7,894
改變 (%) 6.00 14.19 18.39 8.29 35.05 15.31 10.81 6.49 -4.58 3.12 -7.79 -3.71 -10.18 -20.42 2.56 -2.01 1.59 6.09 -1.08
佔收入的百分比 393.06 354.77 8,817.38 7,151.34 3,098.66 142.64 109.67 119.25 116.47 206.73 236.99 160.02 130.33 120.70 108.47 109.41 100.98 80.69 64.94 60.11
研發 16,776 21,096 25,801 27,432 23,932 23,372 21,287 22,556 23,028 20,181 17,867 14,594 11,700 9,681 9,481 9,992 9,289 10,553 9,669 8,950
改變 (%) 25.75 22.31 6.32 -12.76 -2.34 -8.92 5.96 2.09 -12.36 -11.46 -18.32 -19.83 -17.25 -2.07 5.40 -7.04 13.61 -8.38 -7.43
佔收入的百分比 1,593.71 1,706.43 45,426.97 33,086.44 11,549.58 384.46 233.48 242.76 227.31 370.57 364.73 218.14 147.92 126.21 139.58 144.67 126.66 113.19 78.68 68.15
營運支出 22,134 26,802 32,753 35,837 33,380 35,637 34,758 37,151 38,411 35,306 32,731 29,881 27,865 25,753 25,491 26,336 25,772 27,892 28,428 28,465
改變 (%) 21.09 22.20 9.41 -6.85 6.76 -2.47 6.88 3.39 -8.08 -7.29 -8.71 -6.75 -7.58 -1.02 3.31 -2.14 8.23 1.92 0.13
佔收入的百分比 2,102.67 2,168.01 57,666.16 43,223.88 16,108.87 586.21 381.22 399.83 379.14 648.30 668.14 446.63 352.30 335.73 375.30 381.30 351.41 299.18 231.33 216.75
營業收入 -21,081 -25,566 -32,696 -35,754 -33,173 -29,558 -25,640 -27,859 -28,280 -29,860 -27,832 -23,191 -19,956 -18,082 -18,699 -19,429 -18,438 -18,569 -16,139 -15,332
改變 (%) 21.27 27.89 9.35 -7.22 -10.90 -13.25 8.65 1.51 5.59 -6.79 -16.68 -13.95 -9.39 3.41 3.90 -5.10 0.71 -13.09 -5.00
佔收入的百分比 -2,002.67 -2,068.01 -57,566.16 -43,123.88 -16,008.88 -486.22 -281.22 -299.83 -279.14 -548.30 -568.14 -346.63 -252.30 -235.73 -275.30 -281.30 -251.41 -199.18 -131.33 -116.75
利息花費 -41 -41 -518 -864 -1,220 -1,570 -808 -485 -629 -944 -2,471 -3,442 -3,957 -4,307 -4,044 -4,115 -4,515 -4,947 -5,452 -5,241
改變 (%) -0.00 1,169.33 66.69 41.19 28.67 -48.51 -39.98 29.74 49.95 161.77 39.30 14.97 8.85 -6.12 1.77 9.72 9.57 10.20 -3.87
佔收入的百分比 -3.88 -3.30 -912.81 -1,042.38 -588.88 -25.83 -8.87 -5.22 -6.21 -17.33 -50.44 -51.45 -50.03 -56.15 -59.53 -59.58 -61.57 -53.07 -44.37 -39.91
淨利 -20,046 -23,582 -31,637 -32,216 -34,828 -31,947 -29,853 -33,585 -35,515 -30,986 -17,911 -17,407 -15,936 -20,352 -20,644 -21,115 -10,490 -11,730 -17,360 -14,873
改變 (%) 17.64 34.16 1.83 8.11 -8.27 -6.56 12.50 5.75 -12.75 -42.20 -2.82 -8.45 27.71 1.43 2.28 -50.32 11.82 48.00 -14.33
佔收入的百分比 -1,904.33 -1,907.54 -55,701.69 -38,857.17 -16,807.70 -525.52 -327.42 -361.45 -350.56 -568.98 -365.62 -260.18 -201.48 -265.33 -303.93 -305.71 -143.04 -125.81 -141.27 -113.25

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista